Background - Stent thrombosis is a lethal complication of endovascular intervention.
背景-支架血栓是血管内介入手术的致命的并发症。
During the 9 months follow-up period, there were no deaths or cases of stent thrombosis.
在随后的9个月内未发生死亡和支架血栓血栓形成的情况。
No stent thrombosis was observed in any of the patients within 2 years of clinical follow-up.
在接下来2年的临床随访中，均无支架内血栓形成。
But physicians should be concerned that we've not solved the problem of late stent thrombosis.
但是内科医生应注意，我们还没有解决晚期支架血栓形成问题。
No stent thrombosis was observed in the Alpha stent group within 2 years of clinical follow-up.
在接下来2年的临床随访中，阿尔法支架组均没有发现支架内血栓形成。
The cost implications are negligible and the benefits on a reduction in stent thrombosis are large.
这对成本的影响可以忽略不计，而在减少支架血栓形成上的获益却是巨大的。
Attention has recently been focused on late stent thrombosis related to the use of drug-eluting stents.
但最近药物支架晚期血栓的问题倍受关注。
This was associated with worse clinical outcome, in particular, higher rates of TLR and stent thrombosis.
与不良临床结果相关，尤其是较高的TLR(靶病变重建率)和支架血栓的发生率。
Objective To investigate individual variations of platelet inhibition after Plavix being administered to prevent clinic events and stent thrombosis.
目的：研究预防支架术后临床事件和血栓形成服用波力维后，血小板抑制的个体差别。
Stent thrombosis (st) after percutaneous coronary intervention has been the focus of intense interest because of its attendant morbidity and mortality.
经皮冠状动脉介入治疗后的支架血栓形成(ST)一直以来都是人们关注的焦点。
Late stent thrombosis, although a rare event affecting less than 1% of DES patients, is a medical emergency, with patients dying in up to 45% of cases.
支架后血栓是一种医学急性症状，尽管比较罕见，只影响不到1%的DES患者，但能够导致45%的患者死亡。
Methods and Results— Since January 2004, patients presenting with very late stent thrombosis (>1 year) after DES implantation underwent intravascular ultrasound.
方法和结果：从2004年1月起，将DES植入后发生较晚（>1年）发生支架血栓的病人进行血管内超声检查。
The Swedish Coronary Angiography and Angioplasty Registry (SCAAR) did, however, reveal a continuing risk of late stent thrombosis that does not diminish with time.
但是，这项瑞典冠状动脉血管造影及血管成形术注册研究(SCAAR)也显示，晚期支架血栓形成的风险持续存在，并没有随着时间的推移而减少。
This article reviews the clinical evidence and pathophysiological mechanisms of stent thrombosis of drug-eluting stent, especially the role of the stent itself in it.
现对药物涂层支架内血栓形成的相关临床证据和病理生理机制，特别是药物涂层支架本身在其中的作用进行综述。
The present study investigated differences of the stented segment between patients with and without very late stent thrombosis with the use of intravascular ultrasound.
本研究采用冠脉内超声来研究伴或不伴有支架内迟发血栓患者支架部分的差异。
The paper says that stent thrombosis is the "leading adverse event" associated with early antiplatelet discontinuation in patients with DES and carries a mortality rate of 20-45%.
这篇文章中说，对于药物洗脱支架置入的患者，支架内血栓形成是和早期停用抗血小板紧密相关的主要副作用，其死亡率为20%到50%。
Objective: To evaluate the preventive effect of antiplatelet regimens and it′s combination with Shuxinyin (SXY) on coronary events including stent thrombosis after stenting implantation.
目的：观察舒心饮与抗血小板药物联合应用对冠状动脉支架血栓等术后冠脉事件的预防作用。
Conclusions - the most powerful histological predictor of stent thrombosis was endothelial coverage. The best morphometric predictor of LST was the ratio of uncovered to total stent struts.
结论：支架血栓最有力的组织学预测因素是内皮覆盖率，LST最好的形态学预测因素是未覆盖内皮部分占总支架支柱的比例。
Objective to study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
目的：探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。
Objectives: We sought to determine the risk of late stent thrombosis (st) during long-term follow-up beyond 3 years, searched for predictors, and assessed the impact of st on overall mortality.
研究目的：我们通过3年以上的长期随访，试图发现晚期发生的支架内血栓的危险因素，寻找预测因子，并且评估支架内血栓对总死亡率的影响。
Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.
目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。
Objective To investigate the mid-term efficacy of retrievable stent filter placement for the treatment of Budd-Chiari syndrome (BCS) complicated with inferior vena cava (IVC) thrombosis.
目的观察可回收支架治疗下腔静脉阻塞（BCS）合并血栓形成的中期疗效。
Objective To investigate the mid-term efficacy of retrievable stent filter placement for the treatment of Budd-Chiari syndrome (BCS) complicated with inferior vena cava (IVC) thrombosis.
目的观察可回收支架治疗下腔静脉阻塞（BCS）合并血栓形成的中期疗效。
应用推荐